Search clinical trials for: IBI302 (the second dose level)
Total 0 results
Nothing found
Sponsors and Collaborators
- MingSight Pharmaceuticals Pty Limited
- John Granton
- Health Parametrics Inc.
- Wushan County People's Hospital
- Zahra Rabbani Khah
- Mitchell Scheiman
- Jeffrey W. Clark, MD
- New York State Health Foundation
- Ionis Pharmaceuticals
- Rex Bionics Plc
- Marilia Medicine School
- Honda R and D Americas, Inc.
- The Third Hospital of Changsha
- European Network For Smoking and Tobacco Prevention
- Jeffrey Rudolph
- Medtronic Atrial Fibrillation Solutions
- Northern California Melanoma Center
- Montreal Neurological Institute and Hospital
- Kawin Technology Share-holding Co., Ltd.
- CTC Bio, Inc.
- View Full List
Medical Conditions
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Locally Advanced NSCLC
- Ascaris Suum
- Liver Hemangioma
- HDT-AHCT
- Pancreatic Neoplasms
- Periferal Arterial Occlusive Disease, PAOD
- LSIL
- Brain MRI
- Waldenstrom's Macroglobulinemia Recurrent
- H.Pylori Infection
- ACTH-Secreting Pituitary Adenoma
- Metastatic Spine Lesions
- Advanced Esophageal Cancers
- Pregnancy-Related Condition, Unspecified
- Renal Cancer Metastatic
- Primary Generalized Dystonia
- Fasting, Diet, Chemotherapy, Toxicity
- Hyperthyroidism, Autoimmune
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- View Full List
Drug Interventions
- CKD-519
- Pentostatin
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Levcromakalim
- Levobupivacaine, clonidine
- Postoperative analgesia management
- Fludarabine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Hydroxychloroquine
- Ombrabulin (AVE8062)
- Rifaximin
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Bendamustine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Nimotuzumab
- ESK981
- AZD7798
- 200 µg doxorubicin-containing MNA
- Toripalimab plus Anlotinib
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Chile
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Iran
- Contract Research Organizations in Kenya
- Contract Research Organizations in Moldova
- Contract Research Organizations in Poland
- Contract Research Organizations in Russia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Tunisia
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Venezuela
- CRO list by country